Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Yellow Fever Vaccine in Patients With Rheumatic Diseases Under Low Immunosuppression Level and Residing in a Risk Area

NCT03430388 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.

NCT NCT03430388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03430388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Yellow Fever Vaccine in Patients With Rheumatic Diseases Under Low Immunosuppression Level and Residing in a Risk Area
Lead sponsor
University of Sao Paulo General Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2018
Completion date
February 24, 2019
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

granulomatosis with polyangiitis, inflammatory myopathy, juvenile dermatomyositis, juvenile idiopathic arthritis, mixed connective tissue disease, rheumatoid arthritis, sjogren's syndrome, spondyloarthritis, systemic lupus, systemic sclerosis, takayasu arteritis